Frontiers | KHSRP knockdown inhibits papillary renal cell carcinoma progression and sensitizes to gemcitabine

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.